Neuropsychotherapeutics

Neuropsychotherapeutics

1st Edition - August 1, 2019

Write a review

  • Editor: Jeffrey M. Witkin
  • eBook ISBN: 9780128166697
  • Hardcover ISBN: 9780128166680

Purchase options

Purchase options
DRM-free (PDF, Mobi, EPub)
Available
Sales tax will be calculated at check-out

Institutional Subscription

Free Global Shipping
No minimum order

Description

Neuropsychotherapeutics, Volume 86, the newest volume in the Advances in Pharmacology series, presents a variety of chapters from the best authors in the field, with this updated edition including sections on Pharmacotherapy of psychiatric disorders, Allosteric mechanisms for neuropsychopharmacology, Lipid rafts, Rapid-acting antidepressants, mGlu2/3 receptor antagonists, Nitric oxide: antidepressant mechanisms and inflammation, Anxiety disorders, mGlu receptors and schizophrenia, mAChR ligands for schizophrenia and addiction, PDE10 inhibitors, Obsessive-compulsive disorder, Addiction disorders (including eating), Dopamine D1 PAMs as a New Mode for Treatment of Neuropsychiatric Disorders, and more.

Key Features

  • Includes the authority and expertise of leading contributors in pharmacology
  • Presents the latest release in the Advances in Pharmacology series

Readership

Investigators in neuroscience, pharmacology, neurology, psychiatry, medicine

Table of Contents

  • 1. GPCR drug discovery-moving beyond the orthosteric to the allosteric domain
    Christian C. Felder
    2. Lipid rafts in psychiatry
    Nathan H. Wray and Mark M. Rasenick
    3. Rapid-acting antidepressants
    Jeffrey M. Witkin, Anna E. Martin, Lalit K. Golani, Nina Z. Xu and Jodi L. Smith
    4. mGlu2/3 receptor antagonists
    Shigeyuki Chaki
    5. Nitric oxide: Antidepressant mechanisms and inflammation
    Mehdi Ghasemi
    6. Selective allosteric modulation of muscarinic acetylcholine receptors for the treatment of schizophrenia and substance use disorders
    Laura B. Teal, Robert W. Gould, Andrew S. Felts and Carrie K. Jones
    7. Medications development for food-based and drug use disorders
    Fernando B. de Moura, Stephen J. Kohut and Jack Bergman
    8. Obsessive compulsive disorder (OCD): Current treatments and a framework for neurotherapeutic research
    Erik Z. Woody, Kurt Leroy Hoffman and Henry Szechtman
    9. Positive allosteric modulators of the dopamine D1 receptor: A new mechanism for the treatment of neuropsychiatric disorders
    Kjell A. Svensson, Junliang Hao and Robert F. Bruns

Product details

  • No. of pages: 320
  • Language: English
  • Copyright: © Academic Press 2019
  • Published: August 1, 2019
  • Imprint: Academic Press
  • eBook ISBN: 9780128166697
  • Hardcover ISBN: 9780128166680

About the Serial Volume Editor

Jeffrey M. Witkin

Jeffrey M. Witkin, Witkin Consulting Group, IN, USA

Affiliations and Expertise

Witkin Consulting Group, IN, USA

Ratings and Reviews

Write a review

There are currently no reviews for "Neuropsychotherapeutics"